Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Tech Transfer Roundup: Sanofi Gets IP For Multiple Myeloma From Memorial Sloan Kettering

Jul 08 2021

• By Joseph Haas

Tech Transfer

Related Content

Sanofi’s Sarclisa Gets EMA Backing In Myeloma, Mirroring FDA OK

Mar 30 2020

Tech Transfer Roundup: Oncology Deals Focus On CAR-T Innovations, ADCs, DNA Damage Response

Sep 25 2020

BridgeBio’s Hub-And-Spoke Model: An Interview With Cameron Turtle

Mar 01 2021

Related Companies

Sanofi

Eureka Therapeutics, Inc.

Memorial Sloan Kettering Cancer Center

City of Hope

Bristol Myers Squibb Company

Sorrento Therapeutics, Inc.

Karolinska Institutet

Mayo Clinic

Sitryx Therapeutics

Cancer Research UK

Boston Children’s Hospital

ElevateBio, LLC

Avalo Therapeutics, Inc.

Sanford Burnham Prebys Medical Discovery Institute

Lysogene SA

SATT Conectus Alsace

Corbus Pharmaceuticals Holdings, Inc.

University of California San Francisco

BridgeBio Pharma, Inc.

Medical University of South Carolina

Stanford University

University of Pittsburgh

Reset Pharmaceuticals, Inc.

NYU Langone Health

Gyroscope Therapeutics Limited

Children's Medical Research Institute

Kazia Therapeutics Limited

Cornell University

Evonik Industries AG

Silo Pharma, Inc.

Onward Therapeutics SA

Institut du Cancer de Montpellier

Hoth Therapeutics, Inc.

Equillium, Inc.

University of Oxford

ONK Therapeutics Ltd

Walter and Eliza Hall Institute of Medical Research

Trinity College (Dublin)

Expansion Therapeutics, Inc.

Additional Topics

Business Strategies Deals Tech Transfer Round-Up BioPharmaceutical

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window